Pranil K Chandra, DO, FCAP, FASCP
Senior Vice President and Chief Genomics OfficerIn 2011, joined PathGroup as Associate Medical Director of Molecular Pathology and now currently serves as Senior Vice President and Chief Genomics Officer at PathGroup. Holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. Read More
Completed AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center, respectively. While at MD Anderson, served as Chief Fellow and received numerous awards for his research in acute myeloid leukemia. Has presented numerous abstracts and platform presentations at various pathology meetings and has published peer-reviewed articles and book chapters.
Additionally, a member of the American Society of Clinical Pathology, College of American Pathologists, and Association of Molecular Pathology where he also serves in a leadership capacity to the Economic Affairs Committee as Vice-Chair of Coverage. Is a recognized medical consultant in molecular pathology and personalized medicine and am considered a national thought leader in Precision Medicine and Cancer Genomics.
Jianyu Rao, MD, FCAP, FAcadTM, Physician
Professor and Vice Chair of the Department of Pathology at UCLA, Professor of Pathology and Epidemiology, Vice Chair of Technology and Innovation
Dr. Jianyu Rao is a tenured full professor (Step 7) at UCLA School of Medicine, Vice Chair of the Department of Pathology and Laboratory Medicine, Chief of Cytopathology, Director of International Telepathology, and Medical Director of the Cytotechnology Program. Read More
He is a Fellow of College of American Pathologist, Fellow of Academy of Translational Medicine (FAcadTM), Member of Jonsson Comprehensive Cancer Center, Member of California Nanosystem Institute, and Treasurer and Scientific Advisory Board Director of European Society of Translational Medicine. He received Physician of the Year award (2005), International Health Professional and Scientist of the Year (2003, 2006), and Southern California Super Doctors (2022, 2023).
He has 40 years research experiences in cancer risk assessment, early detection, biomarker development, chemoprevention, liquid biopsy, and digital and computational pathology with > 210 peer-reviewed publications, 20 books/book chapters, and an invited speaker in > 200 meetings.
Rao established the first-ever International Telepathology Program, uncovered the role of cytoskeletal actin remodeling in cancer cells, determined molecular mechanisms of anti-cancer effect of green tea, pioneered cancer cell mechanobiological study, and led the study of AI/Machine Learning Tools for Cytology – the “SMART” Cytology.
.